📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology. (2021)

First Author: Codd AS

Attributed to: The TWO Study: A Phase II trial of regulatory T cells in renal transplantation - can we achieve sirolimus monotherapy? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/oxfimm/iqab016

PubMed Identifier: 35593707

Publication URI: http://europepmc.org/abstract/MED/35593707

Type: Journal Article/Review

Volume: 2

Parent Publication: Oxford open immunology

Issue: 1

ISSN: 2633-6960